KOL Identification That Starts with Your Strategy , not a Generic List.

Identify the experts who matter for your specific product, mechanism, and strategy, not just those most visible at a global level.

Find the right KOL for your programme
01
The challenge

The problem with most KOL lists.

Most identification draws on similar data and applies similar scoring logic, regardless of the provider. Because these identification systems must operate across thousands of disease areas and clients, they rely on markers of influence that can be captured and applied consistently at scale, overall publication volume, citation counts, and senior roles in major medical specialty societies.

For these systems, prominence within a specialty is the starting point. Their data and scoring models are designed to generalise, not answer your question.

Whether the list came from a global platform or a specialist provider, if it started with who is prominent and narrowed down, the same names get missed. Not because they do not exist but because the methodology was not built to find them.

Find out more about our identification process
What this means in practice

You probably already know most of the names on them.

Your team needs to know which experts understand your mechanism, are engaged in the evidence you are building on, and can influence the clinical communities that matter to your launch.

Where that matters most
01
Disease-level expertise, not specialty-level prominence
02
Experts beyond the obvious top tier: regional leaders, emerging voices, specialists not yet visible in standard datasets
03
Niche or evolving areas where the literature is sparse
04
Shortlists anchored to your product strategy, not a generic definition of influence

05
A clear rationale for every name on the list, and every name that should be on it
02
in practice

What makes this different in practice.

Specialty prominence doesn’t mean expertise in a disease or mechanism.

A leading specialist is not always the right expert for your product.

In complex conditions, broad clinical standing can mask gaps in specific disease knowledge or patient experience. We deliberately separate these two things, and this critical distinction routinely changes who ends up on the shortlist.

The value is rarely in the names you already know

The senior authors and guideline contributors in your area are not a mystery.

Your competitors know them too and are already trying to engage them. Most providers are good at surfacing that top tier. Below it is where the real value sits, and where most identification falls short.

03
how we help

KOL identification designed for you.

Everything is then designed to provide you with the KOL map you need to plan and execute successful KOL engagement.

  • List of KOLs most suited to your product and strategic goals

  • Detailed information on each KOL to help you decide who to work with and when

  • Deep understanding of how the KOLs see the disease-area and interact with each other

Clients find this bespoke approach particularly useful when they have specific KOL engagement goals, or the KOL landscape the are working in is unique.

01

The mechanism is new, or the field is still forming.

Where the scientific community is small and established KOLs may not yet exist, standard methods fall short. We identify early signals of influence and, where relevant, experts from adjacent fields likely to move into the space.
02

Clinical decision making varies by country or setting.

Where the scientific community is small and established KOLs may not yet exist, standard methods fall short. We identify early signals of influence and, where relevant, experts from adjacent fields likely to move into the space.
03

Engagement with guideline authors is restricted.

In some markets, compliance constraints limit direct engagement with certain guideline contributors. Identification must map the wider expert network shaping those recommendations, including those who influence without being listed.
04
Capabilities

Our capabilities worth knowing about.

Expert interviews as primary research

Where appropriate, we complement desk research with targeted expert interviews to identify who is most respected by established KOLs, understand how clinical thinking is evolving, and surface dynamics not visible in published sources.

Global reach and understanding

Our work combines in-language research, local knowledge, and manual validation to reflect where influence actually sits.

For example, global platforms underrepresent expertise in Japan and China due to language barriers, local publication channels, regional congresses absence from international databases, and transliteration inconsistencies that make automated identification unreliable.

05
case study

What clients find when they compare approaches.

Teams who have worked with large-scale platforms describe the same differences: shortlists composed differently, with regional leaders and emerging experts alongside globally visible figures, a clear rationale for each inclusion, and guidelines or working groups they were not previously aware of.

View case study

What clients find when they compare approaches.

Teams who have worked with large-scale platforms describe the same differences: shortlists composed differently, with regional leaders and emerging experts alongside globally visible figures, a clear rationale for each inclusion, and guidelines or working groups they were not previously aware of.

View case study
The challange

Lorem ipsum dolor sit amet, consectetur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

standard approach

Lorem ipsum dolor sit amet, consectetur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

what changed

Lorem ipsum dolor sit amet, consectetur.

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

01
Sed ut perspiciatis unde omnis.
02
Ut enim ad minima veniam, quis nostrum.
03
At vero eos et accusamus et iusto odio dignissimos ducimus qui blanditiis praesentium.
The outcome

Lorem ipsum dolor sit amet, consectetur adipiscing elit. Ut elit tellus, luctus nec ullamcorper mattis, pulvinar dapibus leo.

  • Lorem ipsum dolor sit amet.

  • Duis aute irure dolor in reprehenderit in voluptate.

  • Sed ut perspiciatis unde omnis iste.

Tell us about your expert landscape

If your current KOL list does not reflect your scientific and strategic reality, or you are heading into an area where standard identification is likely to fall short, we want to understand the challenge.

We will tell you where the gaps are, and whether our approach is the right fit.
Align your KOL strategy to your program

Joe Kendle

Client Services Director

Joe is a cornerstone of Kendle Healthcare, embodying mastery, experience, insight and integrity in everything he delivers.

With more than ten years of experience in KOL Identification and Mapping, Joe’s relationship with Kendle Healthcare began at its foundation. As a university student, he worked on the company’s very first project, gaining early and lasting insight into its standards, values and ambition. That continuity gives him a deep understanding of not just what we do, but why we do it.

After six years in secondary education, Joe returned to healthcare consultancy with a distinctive skill set. His teaching background sharpened his ability to communicate complex ideas with clarity and calm authority. Clients value his measured approach, thoughtful questioning and ability to bring structure to complexity.

Joe’s particular expertise lies in translating technology into meaningful strategic insight. He has been instrumental in advancing the use of Network Mapping within KOL engagement, ensuring that influence is understood in context rather than in isolation. His work combines analytical rigour with practical application, turning data into decisions clients can act on with confidence.

Beyond his professional role, Joe demonstrates integrity through sustained philanthropic commitment. He has raised significant funds for charity through endurance challenges, reflecting resilience, discipline and a strong sense of social responsibility.

Neil Kendle

Managing Director

Neil is more than Managing Director. He is the driving force behind Kendle Healthcare’s standards of mastery, insight and integrity.

With more than three decades of healthcare consultancy experience, Neil brings a depth of understanding that only time and immersion can build. His background as both a Medical Science Liaison and a Brand Manager gives him a rare dual perspective. He understands the priorities of medical professionals and the pressures facing commercial and marketing teams, allowing him to bridge strategy and science with credibility and clarity.

Neil has helped shape the modern healthcare consultancy landscape. He pioneered many of the industry’s established approaches to opinion leader identification and engagement, setting benchmarks that others have since followed. His work has always been grounded in rigorous thinking, ethical practice and a commitment to doing things properly, not simply quickly.

Under his leadership, Kendle Healthcare has earned its reputation for thoughtful strategy, precise execution and trusted partnerships. Clients value his judgement because it is informed by experience, sharpened by insight and guided by integrity.

Outside of work, Neil is a dedicated golfer, a passion he has pursued for more than 25 years. The discipline and focus the game demands mirror the qualities he brings to his professional life: patience, precision and a long term view.